BioSpace News Archive

Press Releases

Dermata Therapeutics Announces $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules

January 23, 2025
·
5 min read
Press Releases

Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer

January 23, 2025
·
5 min read
Press Releases

AIM ImmunoTech Highlights New Article Finding Links Between COVID-19 and ME/CFS

January 23, 2025
·
7 min read
Press Releases

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - January 22, 2025

January 23, 2025
·
1 min read
Press Releases

Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.

January 23, 2025
·
5 min read
Press Releases

Cadonilimab (PD-1/CTLA-4) Phase III Data for First Line Treatment of Advanced Gastric Cancer Published in Nature Medicine

January 23, 2025
·
3 min read
Press Releases

Kelun-Biotech’s Product Tagitanlimab Approved for Marketing in Second Indication in Combination with Cisplatin and Gemcitabine For the First-line Treatment of Patients with recurrent or metastatic NPC

January 23, 2025
·
3 min read
Press Releases

Zerion Pharma and Aché collaborate to exploit the Dispersome® technology for the improvement of two marketed drug products

January 23, 2025
·
1 min read
Press Releases

Findings from pivotal nipocalimab Phase 3 study in a broad antibody positive population of people living with generalized myasthenia gravis (gMG) published in The Lancet Neurology

January 23, 2025
·
15 min read
Press Releases

Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

January 23, 2025
·
5 min read